← VA OIG reports

Deficiencies in Attention Deficit Hyperactivity Disorder Diagnostic Assessment, Evaluation of Stimulant Medication Risks, and Policy Guidance

national-healthcare-review · 2024-04-04 · 22-03013-129

Report

Title
Deficiencies in Attention Deficit Hyperactivity Disorder Diagnostic Assessment, Evaluation of Stimulant Medication Risks, and Policy Guidance
Report number
22-03013-129
Type
national-healthcare-review
Publication date
2024-04-04

Source

Authoritative
VA OIG report page
Machine
JSON-LD · Markdown